Subscribe to Newsletter

Content by William Aryitey:

Outside the Lab Precision medicine

Here Today, Gone Tomorrow

| William Aryitey

A miniature sensor powered by pressure can help monitor vital physiological functions

Outside the Lab Oncology

Taking the EV Option

| William Aryitey

Could a cancer-diagnosing liquid biopsy technique lie within extracellular vesicles?

Diagnostics Oncology

From Neurobiology to Prostate Cancer Pathology

| William Aryitey

The drebrin/EB3 pathway: new therapeutic targets and biomarkers for prostate cancer

Inside the Lab Microbiology and immunology

Exosome Exploration

| William Aryitey

Exosomes may be the key to identifying noninvasive methods to spot transplant rejection

Diagnostics Microbiology and immunology

Cracking the Case of Crohn’s

| William Aryitey

NAPPA, a novel profiling system for Crohn's disease, offers a new diagnostic test and more insight into the disease

Subspecialties Cytology

Cancer Comes Unglued

| William Aryitey

A cell's stickiness may be an indicator of its metastatic state

Outside the Lab Oncology

DESNT: Poor Prognosis Prostate Cancer

| William Aryitey

A novel classification system could mean the end of redundant prostate surgery

Outside the Lab Oncology

Sticking Our Noses into Lung Cancer

| William Aryitey

A novel diagnostic for lung cancer may simply involves taking a nasal swab

Outside the Lab Oncology

FOSL1 Fuels Cancer?

| William Aryitey

A highly expressed transcription factor could be a biomarker for lung and pancreatic cancer

Outside the Lab Microbiology and immunology

The Castleman Criteria

| William Aryitey

Undiagnosed patients with iMCD may be helped by a new set of identification benchmarks

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register